Intii aan ka shaqaynayey nidaamka difaaca, waxaan si lama filaan ah u helay nooc cusub oo unug ah oo dila inta badan kansarka. Horumarka cusubi wuxuu faa'iido weyn u noqon karaa bukaanada kansarka, maadaama unugga cusub ee t-cell uu si wax ku ool ah u dilo badi noocyada unugyada kansarka. Si kastaba ha ahaatee, tani waxay ku koobnayd shaybaarada ilaa hadda, waxaana loo baahan yahay cilmi-baaris dheer oo dheer si loo soo saaro daawada dhamaystiran.
Saynis yahano Ingiriis ah oo ka tirsan Jaamacadda Cardiff Medical University ayaa si lama filaan ah u helay nooc ka mid ah unugyada (T-cell) ee baabi’iya inta badan noocyada kansarka. Sida laga soo xigtay Telegraph tani waxay noqon kartaa daahfurka weyn ee raadinta ugaadhsiga daaweynta kansarka ee dhammaan noocyada kansarka. Dhaqtarku, markii uu baarayay unugyada dhiigga cad ee bangiga dhiigga, wuxuu helay nooc cusub oo t-cell ah oo sita soo-qaade cusub oo horay loo arkay kaas oo u dhaqma sida jilbaha jilicsan, oo ku dheggan inta badan kansarka bini'aadamka, iyada oo la iska indho-tiray unugyada caafimaadka qaba. Wargayska The Telegraph ayaa qoray. Xaaladaha shaybaadhka, unugyada difaaca ee ku qalabaysan soo-dhoweeyaha cusub, waxay awoodeen inay dilaan unugyada kansarka xubno badan, oo ay ku jiraan sambabada, dhiigga, lafaha, iyo kelyaha.
Sida uu sheegayo Professor Andrew Sewell, oo ah madaxa daraasada, khabiirna ku ah nooca unugyada Jaamacadda Caafimaadka Cardiff, Helitaankan waxaa loo isticmaali karaa abuurista daawo caalami ah oo kansar badan.
Kansarka sheegasho agagaarka 10 million ku nool sannad kasta adduunka, iyo saamiga Hindiya waa qiyaas ahaan 8% taas. Tirooyinkani waa kuwo naxdin leh oo sannad walba ku kordhaya habab iyo teknoolojiyad cusub oo loogu talagalay ogaanshaha hore ee kansarka.
The WHO data shows India has around 1.2 million new cases each year, and more than 50% of these cases will be diagnosed in women. Kansarka naasaha has gone up by more than 39% between 1990 and 2016 and is the most common cancer among women. The Lancet report goes on to add that between 1990 and 2016, the number of cancer deaths in India increased by 112 percent. At the same time, the incidence of cancer cases also increased by 48.7 percent. The report also highlights that in 2016, the country had 67,000 lung cancer patients, of which 72.2 percent were men, and kansarka beerka also increased by 32.2 percent since 1990, with 30,000 cases reported in 2016.
Daahfurka cusub ee daaweynta kansarka
Nooc kasta oo caabuq ah, habka difaaca jidhku wuxuu bilaabaa inuu shaqeeyo wuxuuna u dhaqmaa sidii difaac dabiici ah oo ka hortagaya. Si kastaba ha ahaatee, waxay sidoo kale weerartaa unugyada kansarka. Saynisyahano ka tirsan Jaamacadda Cardiff Medical University, Britain, waxay raadinayeen habab aan caadi ahayn oo aan la ogaanin habka difaaca jidhku si dabiici ah u weeraro burooyinka. Waxaa la ogaaday inuu jiro t-cell oo weerara oo dila inta badan noocyada unugyada kansarka.
Sidee ayuu t-unuggani u shaqeeyaa si uu u daweeyo kansarka?
A team at Cardiff Medical University, Britain, discovered a T-cell and its receptor that could find and kill a wide range of cancerous cells in the lab, including lung cancer, skin cancer, blood cancer, colon cancer, breast cancer, kansarka lafaha, prostate cancer, ovarian cancer, kidney cancer, and cervical cancer cells. Exactly how does this happens is yet to be explored and scientists are working on it.
Daaweeye T-cell-ka qaaska ah wuxuu la falgalaa molikiyuul la yiraahdo MR1, kaasoo ku yaal dusha sare ee unug kasta oo jirka aadanaha ka mid ah.
Waxaa laga yaabaa inaad jeceshahay inaad akhriso: Baabuurka T-cell therapy ee Hindiya
Waxaa loo malaynayaa in MR1 uu calaamadinayo dheef-shiid kiimikaadka qalloocan ee ka socda gudaha unugga kansarka ee habka difaaca jirka.
"Waxaan nahay kuwa ugu horreeya ee tilmaamaya T-unugyada MR1 ee unugyada kansarka - oo aan horay loo samayn, tani waa noocii ugu horreeyay," Garry Dolton oo ka tirsan cilmi-baarista ayaa u sheegay. BBC.
Maxay khubaro kale ka yiraahdaan daahfurka daaweynta kansarka?
Lucia Mori iyo Gennaro De Libero, oo ka socda Jaamacadda Basel ee Switzerland, ayaa sheegay in cilmi-baaristu leedahay “karti weyn” laakiin ay tahay xilli hore oo la sheegayo inay ka shaqeyn doonto dhammaan kansarrada.
"Aad ayaan ugu faraxsanahay howlaha difaaca jirka ee dadkan cusub ee T-cell-ka iyo suurtagalnimada adeegsiga TCR-kooda ee daaweynta unugyada burooyinka," ayay yiraahdeen.
Daniel Davis, oo ah borofisar ku takhasusay cilmiga difaaca jirka ee Jaamacadda Manchester, ayaa yiri: “Waqtigan la joogo, tani waa mid cilmi-baaris aasaasi ah oo aan ku dhowayn daawooyinka dhabta ah ee bukaannada.
- Su'aal kama taagna inay tahay daahfur aad u xiiso badan, oo ah horumarinta aqoonta aasaasiga ah ee nidaamka difaaca jirka iyo suurtagalnimada daawooyinka cusub ee mustaqbalka.
Waxaa laga yaabaa inaad jeceshahay inaad akhriso: Daaweynta CAR T Cell ee Shiinaha
